A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Experimental Cell Research

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexcr.2014.05.017PMID 24881818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer statistics, 2013

  2014cited by this paper
• The naringenin‐induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background

  2012cited by this paper
• Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes.

  2012cited by this paper
• Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer

  2012cited by this paper
• Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

  2011cited by this paper
• Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

  2010cited by this paper
• Naringenin and 17β‐estradiol coadministration prevents hormone‐induced human cancer cell growth

  2009cited by this paper
• The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation.

  2008cited by this paper
• Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

  2008cited by this paper
• Long-term Treatment with Tamoxifen Facilitates Translocation of Estrogen Receptor α out of the Nucleus and Enhances its Interaction with EGFR in MCF-7 Breast Cancer Cells

  2007cited by this paper
• Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.

  2007cited by this paper
• The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.

  2006cited by this paper
• Estrogen receptors and human disease.

  2006cited by this paper
• Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.

  2004cited by this paper
• Mechanisms of Naringenin‐induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and ß Signalling

  2004cited by this paper
• Nutritional Flavonoids Modulate Estrogen Receptor α Signaling

  2004cited by this paper
• Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation

  2004cited by this paper
• Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.

  2003cited by this paper
• Targeting the Phosphatidylinositol 3-Kinase / Akt Pathway for Enhancing Breast Cancer Cells to Radiotherapy 1

  2003cited by this paper
• Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes.

  2003cited by this paper
• Arsenic Trioxide Promotes Histone H3 Phosphoacetylation at the Chromatin of CASPASE-10 in Acute Promyelocytic Leukemia Cells*

  2002cited by this paper
• Endocrine-responsive breast cancer and strategies for combating resistance

  2002cited by this paper
• Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

  2002cited by this paper
• Tamoxifen ("Nolvadex"): a review.

  2002cited by this paper
• Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

  2001cited by this paper
• Estrogen Receptor and Breast Cancer

  2001cited by this paper
• Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

  2000cited by this paper
• Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

  1999cited by this paper
• Tamoxifen--the treatment of choice. Why look for alternatives?

  1998cited by this paper
• Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

  1996cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• Functional domains of the human estrogen receptor.

  1987cited by this paper

• Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy

  2025cites this paper
• The therapeutic role of naringenin nanoparticles on hepatocellular carcinoma

  2025cites this paper
• Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells

  2025cites this paper
• Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics

  2024cites this paper
• Hypericin and Naringenin Exert no Significant Synergistic Apoptotic Effect on Y79 Retinoblastoma Cell Line

  2024cites this paper
• Simultaneous estimation of neratinib and naringenin from pharmaceuticals using a stability-indicating liquid chromatographic method: application to analytical quality by design concept and multi-tool method greenness assessment

  2023cites this paper
• Exploring the anti‐cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review

  2023cites this paper
• Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer

  2023cites this paper
• Development of Gelatin Thin Film Reinforced by Modified Gellan Gum and Naringenin-Loaded Zein Nanoparticle as a Wound Dressing

  2022cites this paper
• Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms.

  2022cites this paper
• Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent

  2022cites this paper
• Naringenin and Quercetin Exert Contradictory Cytoprotective and Cytotoxic Effects on Tamoxifen-Induced Apoptosis in HepG2 Cells

  2022cites this paper
• Estrogenic flavonoids and their molecular mechanisms of action.

  2022cites this paper
• Role of Plant-Derived Flavonoids in Cancer Treatment

  2022cites this paper
• Naringenin: A potential flavonoid phytochemical for cancer therapy.

  2022cites this paper
• Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens

  2022cites this paper
• Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway

  2022cites this paper
• Naringenin induces intrinsic and extrinsic apoptotic signaling pathways in cancer cells: A systematic review and meta-analysis of in vitro and in vivo data.

  2022cites this paper
• Naringenin inhibits human breast cancer cells (MDA-MB-231) by inducing programmed cell death, caspase stimulation, G2/M phase cell cycle arrest and suppresses cancer metastasis.

  2021cites this paper
• Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.

  2021cites this paper
• Dietary Naringenin Preserves Insulin Sensitivity and Grip Strength and Attenuates Inflammation but Accelerates Weight Loss in a Mouse Model of Cancer Cachexia.

  2021cites this paper
• antioxidants

  2020cites this paper
• Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer

  2020influential citation
• Research Progress in Flavonoid Anticancer Drugs including synergy with other Approaches.

  2020cites this paper
• Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers

  2020cites this paper
• Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer

  2020cites this paper
• Naringin and naringeninin as anticancer agents and adjuvants in cancer combination therapy; efficacy and molecular mechanisms of action, a comprehensive narrative review.

  2020cites this paper
• Combination of Phytochemicals with Nanotechnology for Targeting GI Cancer Therapy

  2020cites this paper
• Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling Pathway

  2020cites this paper
• Investigation of antitumor properties of semi-synthetic flavonoid derivatives on gynecological cancer cell lines

  2020cites this paper
• Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives

  2019cites this paper
• 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy.

  2019cites this paper
• Synthesis, characterization, anticancer and antioxidant activity of new nickel(II) and copper(II) flavonoid complexes

  2019cites this paper
• Flavonoids as Emerging Anticancer Agents: Current Trends and Recent Advances in Phytotherapy

  2019cites this paper
• Current Aspects of Flavonoids: Their Role in Cancer Treatment

  2019cites this paper
• Synthesis and biological evaluation of acyl derivatives of hydroxyflavones as potent antiproliferative agents against drug resistance cell lines

  2018cites this paper
• Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives

  2018cites this paper
• Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy

  2018cites this paper
• Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.

  2018cites this paper
• Naringenin as a potential immunomodulator in therapeutics.

  2018cites this paper
• Combating oxidative stress disorders with citrus flavonoid: Naringenin

  2018cites this paper
• Binding of naringin and naringenin with hen egg white lysozyme: A spectroscopic investigation and molecular docking study.

  2018cites this paper
• Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9.

  2017cites this paper
• Nonmonotonic responses to low doses of xenoestrogens: A review

  2017cites this paper
• Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach.

  2017cites this paper
• Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells.

  2017cites this paper
• Naringenin Inhibits Proliferation and Survival of Tamoxifen‐ Resistant Breast Cancer Cells

  2017cites this paper
• Biological effects of xenoestrogens and the functional mechanisms via genomic and nongenomic pathways

  2017cites this paper
• Breast Cancer and Flavonoids as Treatment Strategy

  2017cites this paper
• Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.

  2017cites this paper
• Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors.

  2016cites this paper
• Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of naringenin in MCF-7 breast cancer cells

  2016cites this paper
• Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells.

  2016cites this paper
• Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise.

  2016cites this paper
• Chemopreventive and Therapeutic Potential of “Naringenin,” a Flavanone Present in Citrus Fruits

  2015cites this paper
• Role of ER-α36 in breast cancer by typical xenoestrogens

  2015cites this paper
• Copper (II) and 2,2′-Bipyridine Complexation Improves Chemopreventive Effects of Naringenin against Breast Tumor Cells

  2014cites this paper